Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
E-pub ahead of print

Thyroid-stimulating hormone (TSH) is associated with 30-day mortality in hip fracture patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Centenarian hip fracture patients: a nationwide population-based cohort study of 507 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. History of cardiovascular disease and cardiovascular biomarkers are associated with 30-day mortality in patients with hip fracture

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: The aim of this study is to assess the possible association between thyroid-stimulating hormone (TSH) and mortality in hip fracture patients.

PATIENTS AND METHODS: The study is based on a hip fracture database from Bispebjerg University Hospital (Copenhagen, Denmark). This database includes all hip fracture patients (ICD-10 codes DS720 (femoral neck), DS721 (pertrochanteric), and DS722 (subtrochanteric)) admitted to Bispebjerg Hospital from 1996 to 2012. From this database, we identified all surgically treated hip fracture patients aged > 60 years with available plasma TSH-measurements at admission.

RESULTS: Of the 914 included patients (24% men and 76% women), 10.5% died within 30 days. At inclusion, 161 (17.6%) of the patients were hyperthyroid (TSH < 0.65 mIU/L), 58 (6.4%) were hypothyroid (TSH > 4.8 mIU/L), while 695 (76.0%) were euthyroid (0.65 < TSH < 4.80 mIU/L), p = 0.03. Mortality was significantly higher in the two higher quartiles of TSH [Q3 (13.0%) and Q4 (15.4%)] compared to the two lower quartiles [Q1 (7.4%) and Q2 (6.2%), p = 0.0003. After adjustment for age, sex and Charlson Comorbidity Index (CCI) in a Cox proportional hazard model, the risk of 30-day mortality continued to be increased in patients with TSH above the median as compared to patients with TSH below the median (HR 2.1 (1.4-3.3), p = 0.0006].

CONCLUSION: The study demonstrates increased 30-day mortality in surgically treated hip fracture patients with plasma TSH levels above the median (1.41 mIU/L) at admission, even after adjusting for age, sex and CCI.

Original languageEnglish
JournalEuropean journal of trauma and emergency surgery : official publication of the European Trauma Society
ISSN1863-9933
DOIs
Publication statusE-pub ahead of print - 6 Nov 2019

ID: 58330374